Ewan Gray

817 total citations
30 papers, 419 citations indexed

About

Ewan Gray is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Ewan Gray has authored 30 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 12 papers in Oncology and 7 papers in General Health Professions. Recurrent topics in Ewan Gray's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Global Cancer Incidence and Screening (10 papers) and Breast Cancer Treatment Studies (5 papers). Ewan Gray is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Global Cancer Incidence and Screening (10 papers) and Breast Cancer Treatment Studies (5 papers). Ewan Gray collaborates with scholars based in United Kingdom, Switzerland and Australia. Ewan Gray's co-authors include Katherine Payne, Peter Hall, Caroline Vass, Joachim Marti, David Brewster, Jeremy C Wyatt, Jonine D. Figueroa, James Mackay, Paula Lorgelly and Simon Bond and has published in prestigious journals such as Journal of Clinical Oncology, Social Science & Medicine and Journal of Clinical Epidemiology.

In The Last Decade

Ewan Gray

29 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewan Gray United Kingdom 11 170 124 76 59 52 30 419
Olena Mandrik United Kingdom 12 161 0.9× 104 0.8× 51 0.7× 21 0.4× 31 0.6× 38 395
Emeline Aviki United States 15 219 1.3× 278 2.2× 61 0.8× 37 0.6× 47 0.9× 67 673
Leeya F. Pinder United States 14 420 2.5× 75 0.6× 30 0.4× 49 0.8× 66 1.3× 48 700
Misericòrdia Carles-Lavila Spain 12 310 1.8× 60 0.5× 115 1.5× 44 0.7× 46 0.9× 26 475
Seth Wiafe United States 9 317 1.9× 52 0.4× 43 0.6× 73 1.2× 33 0.6× 25 447
Christina A. Minami United States 13 256 1.5× 102 0.8× 101 1.3× 213 3.6× 73 1.4× 56 621
Shridevi Subramaniam Malaysia 12 191 1.1× 74 0.6× 21 0.3× 88 1.5× 35 0.7× 34 376
Tina Žagar Slovenia 14 290 1.7× 57 0.5× 46 0.6× 79 1.3× 26 0.5× 46 546
Angela K. Green United States 12 170 1.0× 93 0.8× 25 0.3× 91 1.5× 27 0.5× 23 508
Maria O. Celaya United States 9 287 1.7× 76 0.6× 37 0.5× 78 1.3× 33 0.6× 13 483

Countries citing papers authored by Ewan Gray

Since Specialization
Citations

This map shows the geographic impact of Ewan Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewan Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewan Gray more than expected).

Fields of papers citing papers by Ewan Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewan Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewan Gray. The network helps show where Ewan Gray may publish in the future.

Co-authorship network of co-authors of Ewan Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Ewan Gray. A scholar is included among the top collaborators of Ewan Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewan Gray. Ewan Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butler, Holly J., Ewan Gray, Paul Brennan, et al.. (2025). Earlier brain tumor detection: Assessing the impact on survival, recurrence, inpatient length of stay and neurological deficit.. Journal of Clinical Oncology. 43(16_suppl).
3.
Wright, Stuart, et al.. (2024). A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied Health Economics and Health Policy. 22(4). 527–542. 1 indexed citations
5.
Maeda, Yasuko, Ewan Gray, Jonine D. Figueroa, et al.. (2021). Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing. BJS Open. 5(4). 5 indexed citations
6.
Luta, Xhyljeta, Marie Fallon, Joanne Droney, et al.. (2021). Healthcare use and costs in the last year of life: a national population data linkage study. BMJ Supportive & Palliative Care. 14(e1). e885–e892. 22 indexed citations
7.
Xin, Yiqiao, Ewan Gray, Robert Heggie, et al.. (2021). From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R. Applied Health Economics and Health Policy. 20(2). 149–158. 2 indexed citations
8.
Gray, Ewan, Jonine D. Figueroa, Olga Oikonomidou, et al.. (2021). Variation in chemotherapy prescribing rates and mortality in early breast cancer over two decades: a national data linkage study. ESMO Open. 6(6). 100331–100331. 5 indexed citations
9.
Thorn, Joanna, Charlotte Davies, Sara Brookes, et al.. (2020). Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey. Value in Health. 24(4). 539–547. 26 indexed citations
10.
Baxter, Gabrielle, et al.. (2020). A meta-analysis comparing the diagnostic performance of abbreviated MRI and a full diagnostic protocol in breast cancer. Clinical Radiology. 76(2). 154.e23–154.e32. 46 indexed citations
11.
McManus, Emma, et al.. (2019). Barriers and Facilitators to Model Replication Within Health Economics. Value in Health. 22(9). 1018–1025. 6 indexed citations
12.
Gray, Ewan, et al.. (2019). Real-world evidence was feasible for estimating effectiveness of chemotherapy in breast cancer: a cohort study. Journal of Clinical Epidemiology. 109. 125–132. 4 indexed citations
13.
Gray, Ewan, et al.. (2019). Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort study. PLoS Medicine. 16(12). e1003006–e1003006. 10 indexed citations
14.
Gray, Ewan, et al.. (2018). PCN79 - DECISION IMPACT OF A 21-GENE SIGNATURE IN EARLY BREAST CANCER: A NATURAL EXPERIMENT USING ROUTINE DATA. Value in Health. 21. S27–S27. 1 indexed citations
15.
Gray, Ewan, et al.. (2018). Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data. British Journal of Cancer. 119(7). 808–814. 40 indexed citations
17.
Gray, Ewan, Nico Karssemeijer, Carla H. van Gils, et al.. (2017). Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis. Value in Health. 20(8). 1100–1109. 46 indexed citations
18.
19.
Fichera, Eleonora, Ewan Gray, & Matt Sutton. (2016). How do individuals’ health behaviours respond to an increase in the supply of health care? Evidence from a natural experiment. Social Science & Medicine. 159. 170–179. 7 indexed citations
20.
Gray, Ewan, et al.. (2016). Direct costs of interferon‐based and interferon‐free direct‐acting antiviral regimens for the treatment of chronic hepatitis C infection. Journal of Viral Hepatitis. 23(9). 677–686. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026